• Disrupting c-Myc/Max: Strategic Pathways from Mechanistic...

  2025-10-22

  Explore how 10058-F4, a novel small-molecule c-Myc-Max dimerization inhibitor, is revolutionizing translational cancer research. This thought-leadership article bridges deep mechanistic insight—spanning apoptosis, telomerase regulation, and stem cell biology—with actionable strategic guidance for translational researchers. Integrating the latest findings on TERT transcriptional regulation, we define a new frontier for apoptosis assays, acute myeloid leukemia models, and beyond. Discover how 10058-F4 enables unprecedented exploration of oncogenic pathways and positions itself for next-generation translational oncology.

• Caspase-8 Fluorometric Assay Kit: Precision Apoptosis Ass...

  2025-10-21

  Unlock unparalleled sensitivity in IETD-dependent caspase activity detection with the Caspase-8 Fluorometric Assay Kit. This streamlined platform accelerates apoptosis research, offering robust quantification in cancer therapy, neurodegenerative disease models, and caspase signaling studies—outperforming conventional methods with speed and reliability.

77 records 6/6 page Previous First page 上5页 6